Cross-Titration from Olanzapine to Risperidone

Introduction to Cross-Titration

The American College of Psychiatry recommends a gradual 2-week cross-titration strategy when switching from olanzapine to risperidone, maintaining olanzapine at full dose for week 1 while starting risperidone, then reducing olanzapine to 5mg in week 2, before complete discontinuation at week 3, as supported by evidence from The Lancet Psychiatry 1
International schizophrenia guidelines, as reported in The Lancet Psychiatry, recommend gradual cross-titration informed by the half-life and receptor profile of each medication 1

Start risperidone 1mg at bedtime while continuing olanzapine 10mg at its current schedule, and increase risperidone by 1mg every 2-3 days until reaching 4mg nocte by end of week 1, as recommended by The Lancet Psychiatry 1

Monitor daily for akathisia, dystonia, and rigidity, particularly as risperidone exceeds 2mg daily, as recommended by the National Institute of Mental Health 2
Risperidone doses greater than 6mg daily significantly increase EPS risk without additional therapeutic benefit, according to the National Institute of Mental Health 2
Check orthostatic vital signs daily during week 1, as both medications cause orthostatic hypotension, as reported by the American Geriatrics Society 2, 3
Assess for breakthrough positive symptoms or negative symptoms indicating inadequate antipsychotic coverage, as recommended by the National Alliance on Mental Illness 2, 3

For first-episode or adolescent patients, consider starting with risperidone 0.5mg and titrating more slowly to a lower target dose of 2-3mg daily, as recommended by the British Journal of Psychiatry and the American Academy of Child and Adolescent Psychiatry 4
For elderly patients, use a more conservative approach with slower titration and lower target doses, and monitor more closely for orthostatic hypotension, falls, and sedation, as recommended by the American Geriatrics Society 3